Anúncio
Anúncio
AGIO
Agios Pharmaceuticals, Inc.
28.41
USDPatrocinado
+0.25
+0.89%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
28.41
0.00
0.00%
Relatórios de Lucros AGIO
Rácio de surpresa positiva
AGIO separação 26 de 39 últimas estimativas.
67%
Próximo Relatório
Data do Próximo Relatório
11 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$12.38M
/-$1.99
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-3.89%
/+11.80%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+15.36%
/+38.19%
Agios Pharmaceuticals, Inc. earnings per share and revenue
On 30 de out. de 2025, AGIO reported earnings of -1.78 USD per share (EPS) for Q3 25, beating the estimate of -1.93 USD, resulting in a 8.09% surprise. Revenue reached 12.88 milhão, compared to an expected 10.63 milhão, with a 21.22% difference. The market reacted with a +2.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -1.99 USD, with revenue projected to reach 12.38 milhão USD, implying an aumentar of 11.80% EPS, and diminuir of -3.89% in Revenue from the last quarter.
FAQ
What were Agios Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Agios Pharmaceuticals, Inc. reported EPS of -$1.78, beating estimates by 8.09%, and revenue of $12.88M, 21.22% above expectations.
How did the market react to Agios Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 2.91%, changed from $41.96 before the earnings release to $43.18 the day after.
When is Agios Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 11 de fev. de 2026.
What are the forecasts for Agios Pharmaceuticals, Inc.'s next earnings report?
Based on 12
analistas, Agios Pharmaceuticals, Inc. is expected to report EPS of -$1.99 and revenue of $12.38M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio